GHISLAINE MAXWELL
GHISLAINE MAXWELL
For the Period 5/I/I I to 8/31/11
Account Summary
Asset Allocation Beginning Ending Change Estimated Current Asset Allocation
Market Value Market Value In Value Annual Income Allocation
Equity
Alternative Assets 410,049.00 447,642.00 37,593.00 16,932.50 21%
60,948.00 79,876.00 18,928.00 4%
Cash 8 Fixed Income 1.564.396.30 1,528,235.17 (36.161.13) 67,580.63 75%
Market Value
Accruals $2,036,393.30
33,026.74 $2,066,763.17
29,617.91 $20,369.87
(3,408.83) $84,613.13 100%
Market Value with Accruals $2,068,420.04 $2,086,371.08 $16,961.04
Portfolio Activity Current
Period Value Year-to-Date
Value
Beginning Market Value 2,035,393.30 1,946,279.39
Contributions 16,850.61 16,850.61
Withdrawals & Fees (269.80) (1,288.81)
Securities Transferred In 884,911.95 4,198,650.57
Secuntes Transferred Out (897,138.13) (4,538,111.43)
Net Contributions/Withdrawals $4,354.63 ($323,879.06)
Income & Distributions 7,461.34 19,876.99
Change In Investment Value 8,543.90 413,475.85
Ending Market Value $2,065,763.17 $2,065,753.17
Accruals 29617.91 29 817.91
Market Value with Accruals $2,086,371.09 $2,086,371.08
JP Morgan Agnew ASS
Cana Pawl &worn.
Page 2 of 22
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL JPM-SDNY-00048001
SDNY_GM_00317199
EFTA01520674